230 related articles for article (PubMed ID: 38003537)
21. FTO deficiency in older livers exacerbates ferroptosis during ischaemia/reperfusion injury by upregulating ACSL4 and TFRC.
Li R; Yan X; Xiao C; Wang T; Li X; Hu Z; Liang J; Zhang J; Cai J; Sui X; Liu Q; Wu M; Xiao J; Chen H; Liu Y; Jiang C; Lv G; Chen G; Zhang Y; Yao J; Zheng J; Yang Y
Nat Commun; 2024 Jun; 15(1):4760. PubMed ID: 38834654
[TBL] [Abstract][Full Text] [Related]
22. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
23. Homeobox-D 1 and FTO form a transcriptional-epigenetic feedback loop to promote head and neck cancer proliferation.
Zhang C; Xie L; Lin Z
Cell Biol Int; 2023 Dec; 47(12):1987-1998. PubMed ID: 37655555
[TBL] [Abstract][Full Text] [Related]
24. m
Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma.
Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y
Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648
[TBL] [Abstract][Full Text] [Related]
26. An Acid-Responsive Iron-Based Nanocomposite for OSCC Treatment.
Zhao X; Leng D; Wang H; Jin H; Wu Y; Qin Z; Wu D; Wei X
J Dent Res; 2024 Jun; 103(6):612-621. PubMed ID: 38684484
[TBL] [Abstract][Full Text] [Related]
27. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
28. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
Ji FH; Fu XH; Li GQ; He Q; Qiu XG
Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
[TBL] [Abstract][Full Text] [Related]
29. Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells.
Han L; Li L; Wu G
Mol Cell Probes; 2022 Aug; 64():101821. PubMed ID: 35490795
[TBL] [Abstract][Full Text] [Related]
30. Rhamnazin Inhibits Hepatocellular Carcinoma Cell Aggressiveness in Vitro via Glutathione Peroxidase 4-Dependent Ferroptosis.
Mei F; Liu Y; Zheng S
Tohoku J Exp Med; 2022 Sep; 258(2):111-120. PubMed ID: 35896364
[TBL] [Abstract][Full Text] [Related]
31. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.
Lee J; Roh JL
Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895
[TBL] [Abstract][Full Text] [Related]
32. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
[TBL] [Abstract][Full Text] [Related]
33. Combination treatment with ferroptosis and autophagy inducers significantly inhibit the proliferation and migration of oral squamous cell carcinoma.
Zhang L; Li Z; Ma X; Yang W; Hao Y; Zhang L; Piao S
Biochem Biophys Res Commun; 2024 May; 709():149842. PubMed ID: 38554601
[TBL] [Abstract][Full Text] [Related]
34. Fat mass and obesity-associated protein regulates arecoline-exposed oral cancer immune response through programmed cell death-ligand 1.
Li X; Chen W; Gao Y; Song J; Gu Y; Zhang J; Cheng X; Ai Y
Cancer Sci; 2022 Sep; 113(9):2962-2973. PubMed ID: 35289035
[TBL] [Abstract][Full Text] [Related]
35. A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria.
Wu S; Mao C; Kondiparthi L; Poyurovsky MV; Olszewski K; Gan B
Proc Natl Acad Sci U S A; 2022 Jun; 119(26):e2121987119. PubMed ID: 35749365
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Xu Y; Li X; Cheng Y; Yang M; Wang R
FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
[TBL] [Abstract][Full Text] [Related]
37. USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy.
Li H; Sun Y; Yao Y; Ke S; Zhang N; Xiong W; Shi J; He C; Xiao X; Yu H; Dai P; Xiang B; Xing X; Xu G; Song W; Song J; Zhang J
Proc Natl Acad Sci U S A; 2024 Apr; 121(16):e2315541121. PubMed ID: 38598341
[TBL] [Abstract][Full Text] [Related]
38. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
[TBL] [Abstract][Full Text] [Related]
39. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
[TBL] [Abstract][Full Text] [Related]
40. Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma.
Qiu L; Tao A; Liu F; Ge X; Li C
BMC Genom Data; 2022 Nov; 23(1):80. PubMed ID: 36384476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
